The Spontaneous CD8+ T-Cell Response to HLA-A2-Restricted NY-ESO-1b Peptide in Hepatocellular Carcinoma Patients
Xiaoying Shang(Fujian Normal University), Weifeng Chen(Peking University), Xi-sheng Leng(Peking University), Gerd Ritter(Memorial Sloan Kettering Cancer Center), Sacha Gnjatic(Tisch Hospital), Lloyd J. Old(Gynecologic Oncology Group), Huan Qiao(Vanderbilt University Medical Center), Hongsong Chen(Inner Mongolia University for Nationalities), Liling Qin(Sichuan Mianyang 404 Hospital), Ran Fei(Peking University), Jirun Peng(Peking University), Andrew J.G. Simpson(Swansea University), Ming-hui Mei(Affiliated Hospital of Guilin Medical College), Xuewen Pang(Peking University), Hua–Gang Zhang(Peking University)
Cited by 66
Related Papers
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
|Proceedings of the National Academy of Sciences|2005|2.4k
Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
|New England Journal of Medicine|2012|2.1k
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
|Nature Reviews Clinical Oncology|2021|1.5k